1 Fisher M, Feuerstein G, Howells D W, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stoke,2009, 40: 2244–2250
[2]
2 Bobo R H, Laske D W, Akbasak A, et al. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA, 1994, 91:2076–2080？？
[3]
3 Debinski W, Tatter S B. Convection-enhanced delivery for the treatment of brain tumors. Expert Rev Neurother, 2009, 9: 1519–1527？？
[4]
4 Gallia G L, Brem S, Brem H. Local treatment of malignant brain tumors using implantable chemotherapeutic polymers. J Natl ComprCancer Netw, 2005, 3: 721–728
[5]
5 He Q, Han H, Xu F, et al. Imaging and quantitative measurement of brain extracellular space using MRI Gd-DTPA tracer method. Journalof Peking University (Health Sciences), 2010, 42: 188–191
[6]
6 Krauze M T, Forsayeth J, Park J W, et al. Real-time imaging and quantification of brain delivery of liposomes. Pharm Res, 2006, 23:2493–2504？？
[7]
7 Fresta M, Puglisi G, Di Giacomo C, et al. Liposomes as in vivo carriers for citicoline: effects on rat cerebral post-ischaemic reperfusion. JPharm Pharmacol, 1994, 46: 974–981
[8]
8 Caravan P, Ellison J J, McMurry T J, et al. Gadolinium(iii) chelates as mri contrast agents: structure, dynamics, and applications. Chem Rev,1999, 99: 2293–2352？？
[9]
9 Longa E Z, Weinstein P R, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 1989, 20:84–91
[10]
10 Joshi C N, Jain S K, Murthy P S. An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts. Brain Res BrainRes Protoc, 2004, 13: 11–17？？
[11]
11 Moseley M E, Cohen Y, Mintorovitch J, et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion- andT2-weighted MRI and spectroscopy. Magn Reson Med, 1990, 14: 330–346？？
[12]
12 Overgaard K, Meden P. Citicoline--the first effective neuroprotectant to be combined with thrombolysis in acute ischemic stroke? J NeurolSci, 2006, 247: 119–120
[13]
13 Minnerup J, Schabitz W R. Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics, 2009, 6: 43–52？？
[14]
14 Cho H J, Kim Y J. Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases. Methods Find ExpClin Pharmacol, 2009, 31: 171–176
[15]
15 Clark W M, Wechsler L R, Sabounjian L A, et al. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke,1999, 30: 2592–2597
[16]
16 Clark W M, Wechsler L R, Sabounjian L A, et al. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic strokepatients. Neurology, 2001, 57: 1595–1602
[17]
17 Clark W M. Efficacy of citicoline as an acute stroke treatment. Expert Opin Pharmacother, 2009, 10: 839–846？？
[18]
18 Adibhatla R M, Hatcher J F. Citicoline mechanisms and clinical efficacy in cerebral ischemia. J Neurosci Res, 2002, 70: 133–139？？
[19]
19 Sykova E, Nicholson C. Diffusion in brain extracellular space. Physiol Rev, 2008, 88: 1277–1340？？
